戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ratoderma (PPK) severely impairs mobility in pachyonychia congenita.
2 e as therapeutic agents for the treatment of pachyonychia congenita.
3 he prevalence and characteristics of itch in pachyonychia congenita.
4 ic siRNAs for epidermolysis bullosa simplex, pachyonychia congenita and Messmann epithelial corneal d
5 By comparison, other hereditary PPKs such as pachyonychia congenita and Olmsted syndrome show prevale
6 atin 16 (Krt16), one of the genes mutated in pachyonychia congenita, develop pachyonychia congenita-l
7 expression of the two other genes mutated in pachyonychia congenita diseases, K6 and K16, with that o
8 ndages and directly support the concept that pachyonychia congenita is a disease of the nail bed.
9                                              Pachyonychia congenita is caused by mutations in keratin
10 s mutated in pachyonychia congenita, develop pachyonychia congenita-like PPK.
11 ited mutations in this gene can cause either pachyonychia congenita or steatocystoma multiplex, the f
12 RT6 family, such as in KRT6A and KRT6B cause pachyonychia congenita (PC) -1 and -2, respectively.
13 ating lesions that arise in individuals with pachyonychia congenita (PC) and feature upregulation of
14    Palmoplantar keratoderma is a hallmark of pachyonychia congenita (PC) and focal non-epidermolytic
15                                              Pachyonychia congenita (PC) is a dominantly inherited ge
16                                              Pachyonychia congenita (PC) is a genetic disorder of ker
17                                              Pachyonychia congenita (PC) is a group of autosomal domi
18                                              Pachyonychia congenita (PC) is a keratinizing disorder p
19                                              Pachyonychia congenita (PC) is a rare autosomal dominant
20                                              Pachyonychia congenita (PC) is a rare, autosomal dominan
21                                              Pachyonychia congenita (PC) is an autosomal dominant gen
22                                              Pachyonychia congenita (PC) is an autosomal-dominant ker
23 of small interfering RNA (siRNA; TD101) into pachyonychia congenita (PC) patient foot lesions resulte
24 D101) that targets the causative mutation in pachyonychia congenita (PC) patients.
25 ning overlapping phenotypes between FPPK and pachyonychia congenita (PC) will continue because only o
26                       A notable exception is pachyonychia congenita (PC), a disorder in which the nai
27 rtner type II keratin 6 (Krt6a, Krt6b) cause pachyonychia congenita (PC), a disorder typified by dyst
28  altering the coding sequence of KRT16 cause pachyonychia congenita (PC), a rare autosomal dominant d
29 sorders apparented to ectodermal dysplasias, pachyonychia congenita (PC), and steatocystoma multiplex
30  genes, KRT6A, KRT6B, KRT16, or KRT17, cause pachyonychia congenita (PC), characterized by hypertroph
31 onsible for the rare monogenic skin disorder pachyonychia congenita (PC), we demonstrate that small i
32 ytes from Krt16 null mouse skin, a model for pachyonychia congenita (PC)-associated palmoplantar kera
33 b clinical trial for the rare skin disorder, pachyonychia congenita (PC).
34 arly childhood often suggests a diagnosis of pachyonychia congenita (PC).
35 sense mutations at the KRT16 locus can cause pachyonychia congenita (PC, OMIM:167200) or focal non-ep
36 otype in the type 2 (Jackson-Lawler) form of pachyonychia congenita, previously shown to arise from i
37 riven by a patient support organization, the Pachyonychia Congenita Project.
38 etically confirmed PC from the International Pachyonychia Congenita Research Registry who completed a
39                      Given that all forms of pachyonychia congenita show an involvement of the nail,
40  feature of dermatoses such as psoriasis and pachyonychia congenita, the currently unclear regulation
41 usions: (i) K6a or K16 mutations produce the pachyonychia congenita type 1 phenotype, whereas K17 (or
42                                              Pachyonychia congenita type 2 (PC-2), also known as Jack
43               Epithelial tissues affected in pachyonychia congenita type 2 express the keratin pair K
44                                              Pachyonychia congenita type 2 is an inherited ectodermal
45 although their absence does not preclude the pachyonychia congenita type 2 phenotype.
46 ysts; and (iv) natal teeth are indicative of pachyonychia congenita type 2, although their absence do
47 17 gene (KRT17A) in patients presenting with pachyonychia congenita type 2.
48 notype, whereas K17 (or K6b) mutations cause pachyonychia congenita type 2; (ii) the presence of pilo
49 s following puberty is the best indicator of pachyonychia congenita type 2; (iii) prepubescent patien
50                       Thirteen patients with pachyonychia congenita types 1 and 2 were studied, two o
51 y establishes useful diagnostic criteria for pachyonychia congenita types 1 and 2, which will help li